Benzoyl peroxide (BzPO) is a free radical generating compound that acts as a tumor promoter and progressor in mouse skin. BzPO is cleaved in the presence of copper to produce benzoyloxyl and phenyl radicals. Treatment of mutation reporter plasmids with BzPO and copper yields predominantly single-strand breaks and G->T transversion mutations. To explore the role of base modifications in the possible mammalian mutagenicity of BzPO the formation of 8-hydroxy-2'-deoxyguanosine (8-OHdG) within the DNA of cultured murine keratinocytes was investigated. Treatment with 10 |iM BzPO produced a maximum 3-fold increase in levels of 8-OHdG versus vehicle controls within 1-2 h, with significant levels of 8-OHdG persisting 6 h after initial exposure to BzPO. Pretreatment with the copper chelator bathocuproine disulfonic acid reduced the levels of 8-OHdG generated by BzPO to near background. However, treatment with the iron chelator desferal did not The stable metabolic product of BzPO benzoic acid was ineffective in producing 8-OHdG. Depletion of cellular glutathione with L-buthionine-(S,ff)-sulfoximine increased the amount of BzPO-generated 8-OHdG, while supplementation with glutathione monoethyl ester reduced the number of 8-OHdG molecules formed. Collectively, these results suggest that BzPO at non-cytotoxic concentrations undergoes copper-dependent activation to a reactive product to generate 8-OHdG within cultured murine keratinocytes.
Introduction
Benzoyl peroxide (BzPO*) is a free radical generating compound used in the manufacturing of plastics and polymers, as a bleaching agent in food and as an active ingredient in nonprescription medications (1) . Because of its widespread use, BzPO has undergone extensive toxicological evaluation. BzPO is not carcinogenic as a single agent in animal bioassays. However, potential concern over human exposure to BzPO has arisen subsequent to reports that BzPO acts as a tumor promoter in several strains of mice following initiation with chemical carcinogens (2, 3) . Moreover, BzPO enhances the rate of malignant conversion of benign papillomas in the skin (4, 5) . These effects of BzPO suggest that it may be damaging to the genome, given that malignant conversion is typically facilitated
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by the cutaneous application of genotoxic agents such as urethane, N-methyl-W-nitro-yV-nitrosoguanidine and 4-nitroquinoline-A'-oxide. Several studies using alkaline elution techniques have shown that BzPO causes DNA strand breaks in a number of cell types, including primary cultures of leukocytes and epithelial cells, as well as immortalized epidermal cell lines (6) (7) (8) .
BzPO undergoes Cu(I)-dependent activation to alkoxyl and aryl radicals in keratinocytes (9) . Studies on the mechanism of formation of single-strand breaks in <|)X174 plasmid DNA by BzPO implicate a role for the benzoyloxyl radical (10). Recent studies demonstrated that in vitro exposure to BzPO caused both large and small deletions, as well as point mutations, in the reporter gene supF after replication in human cells (11). BzPO-induced mutagenesis was markedly enhanced by co-addition of Cu(I). A majority of the point mutations generated by co-treatment with BzPO and copper occurred at G-C base pairs, with the principal mutation being a G-»T transversion. Gas chromatography-mass spectrometry was used to demonstrate that treatment of the plasmid pCMVPgal with BzPO caused promutagenic damage in DNA (12) . While a broad range of modified DNA bases were produced by treatment with BzPO and copper, levels of the guanine-derived modified base 8-hydroxyguanine were elevated to die highest net amount. Conformational changes resulting from incorporation of 8-hydroxy-2'-deoxyguanosine (8-OHdG) within an oligonucleotide produce base pairing with deoxycytosine as well as deoxyadenosine (13) . In replicating cells incorporation of deoxyadenosine into the complementary strand opposite 8-OHdG results in G->T transversions. Formation of 8-OHdG within DNA has been associated with the carcinogenesis process in several systems (14) (15) (16) . In the present study noncytotoxic concentrations of BzPO were added to cultured keratinocytes to determine whether potential promutagenic lesions in DNA would be produced in mammalian cells.
Materials and methods

Chemicals
BzPO, benzoic acid, A'.A'-dimethylformamide (DMF), 2'-deoxyguanosine, Lbuthionine-{SJ?)-sulfoximine (BSO), bathocuproine disulfonic acid (BCS) and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (Mil) were obtained from Sigma Chemical Co. (St Louis, MO), while desferal (deferoxamine mesylate) was obtained from Ciba-Geigy (Summit, NJ). DMF was redistilled before use. Proteinase K, RNase A, DNase I, nuclease PI and alkaline phosphatase was obtained from Boehringer Mannheim (Indianapolis, IN). Glutathione monoethyl ester was synthesized by the method of Anderson et al. (17) . 8-OHdG was synthesized as described by Wei and Frenkel (18) . All other reagents were of the highest quality obtainable commercially.
Cell line derivation, culture and treatment
The keratinocyte cell line 308 was donated by Dr James E.Strickland of the National Cancer Institute. This cell line was derived from BALB/c mouse skin initiated in vivo with 7,12-dimethylbenz[a]anthracene and promoted with 12-0-tetradecanoylphorbol-13-acetate and is resistant to Ca 2+ -induced terminal differentiation (19 
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150X25 mm INTERGRID tissue culture dishes (Becton Dickinson Labware, Lincoln Park, NJ) and allowed to grow until 95% confluent DMF was used as the vehicle for BzPO and added to a final concentration of 0.01%. As indicated, cells were treated with 100 uM BCS or desferal beginning 15 min prior to BzPO addition. Glutathione depletion (>90%, as determined by fluorometric assay for reduced glutathione (20) ) was accomplished in these cells by an 18 h pretreatment with 100 \iM BSO. Glutathione monoethyl ester was added 1 h before BzPO addition. Following treatment cells were washed twice with 10 ml Dulbecco's phosphate-buffered saline, pH 7.4, unless otherwise specified.
Determination of cell viability
The toxicity of BzPO was determined by assay for the reduction of the tetrazolium-based compound MTT (21) . Cells were plated at a density of 2500 cells/well into 96-well tissue culture plates. Cells were treated with the indicated concentrations of BzPO for 24 h, after which time 0.1 mg MTT (50 |ll 2 mg/ml solution in 1X phosphate-buffered saline, pH 7.4) was added to each well. Following a 4 h incubation period the medium was removed and 100 nl Me 2 SO were added to each well to dissolve the MTT reduction product. Only live cells have the mitochondrial dehydrogenase activity required for reduction of MTT to its blue formazan product. This product has an absorbance maximum at 505 nm in Me2SO and thus the number of viable cells could be calculated from the blank-subtracted ASOJ values determined with a microtiter plate reader.
Measurement of 8-OHdG
For analysis of 8-OHdG cells were harvested after treatment using a Cell Lifter (COSTAR, Cambridge, MA) and placed in 20 ml phosphate-buffered saline. Cells were then centrifuged for 10 min at 1500 g. DNA was then isolated using the A.S.A.P. genomic DNA isolation kit (Boehringer Mannheim Biochemicals, Indianapolis, IN). In brief, pelleted cells were resuspended in the designated lysis buffer and treated with 60 u.1 10 mg/ml RNase A for 30 min at 37°C. This step was followed by addition of proteinase K and incubation at 55°C for 30 min. The resulting solution Was then added to an anion exchange column. DNA was eluted using a salt wash provided in the A.S.A.P. kit, precipitated by adding 2 ml isopropanol and stored at -20°C for 18 h. DNA samples were centrifuged at 17 200 g for 20 min. The supernatant was removed and the DNA pellet was washed twice with 500 u.1 ethanol. DNA was then dissolved in 200 JJ. 1 10 mM Tris-HCl, pH 7.0.
DNA was enzymatically digested as described by Wei and Frenkel (18) . Briefly, DNA (100 ug) from 308 cells was dissolved in 200 ul 10 mM Tris-HCl and 100 mM NaCl, pH 7.0. DNase I (100 U) in 40 Hi 10 mM Tris-HCl, pH 7.0 and 10 ul 0.5 M MgCl 2 (final concentration 20 mM) were added. The mixture was then incubated for 1 h at 37°C. The pH of the mixture was adjusted with 15 u.1 0.5 M sodium acetate, pH 5.1, and 10 u.1 nuclease PI (5 U) was added along with 30 (il 10 mM ZnSO 4 and incubated for 1 h at 37°C. The pH was then re-adjusted with 100 ul 0.4 M Tris-HCl, pH 7.8, and 20 p.1 alkaline phosphatase (3 U) were added and incubated for 0.5 h. Digestion of the DNA was terminated by addition of 1 ml acetone and maintenance at -20°C for 0.5 h. Samples were centrifuged at 10 000 g for 10 min and the supernatant dried in a rotary evaporator under reduced pressure. The sample was then dissolved in 200 |il deionized H 2 O and filtered through a 0.2 |im syringe filter.
The amounts of 2'-deoxyguanosine and 8-OHdG were quantified from the areas under their peaks using an HPLC system consisting of a Model 501 Waters solvent delivery system (Waters Associates, Milford, MA), Model 7125 syringe loading sample injector (Rheodyne Inc., Cotati, CA), ZORBAX octadecylsilane 4.6 mmX25 cm analytical column (DuPont, Wilmington, DE), Waters 490E programmable wavelength detector set at 260 nm and a Shimadzu L-ECD-6A electrochemical detector (Shimadzu Corp., Kyoto, Japan) set at 600 mV. The method for HPLC electrochemical detection was similar to the method of Beehler et al. (22) . The mobile phase consisted of 0.15% acetic acid in 1 1 deionized H 2 O, pH 5.5, with 0.5% acetonitrile. The mobile phase was then degassed and vacuum filtered through a 0.2 Jim filter (Nalgene, Rochester, NY). The flow rate was 1.4 ml/min.
Statistical analyses
The amount of 8-OHdG present in samples was expressed per 10 5 2'-deoxyguanosine. Standard curves were generated for both 2'-deoxyguanosine and 8-OHdG and samples quantitated based on line functions obtained from standards. Statistical significance between sample groups was determined using a one-way ANOVA followed by Bonferroni multiple comparison.
Results
Cytotoxicity of BzPO
As shown in Figure 1 , addition of BzPO produced a dosedependent toxicity to cultured keratinocytes. Concentrations 318 •Differs from vehicle control, P < 0.05. 5=30 \iM produced significant reductions in cell viability while concentrations =£10 ^M had no effect on cell viability, as monitored by MTT reduction. On the basis of these results a non-toxic concentration of 10 jiM BzPO was utilized in most subsequent experiments.
BzPO mediated formation of 8-OHdG
The time course for formation of 8-OHdG following exposure of keratinocytes to 10 ^.M BzPO is shown in Figure 2A . Levels of 8-OHdG in keratinocyte DNA increased within 15 min of treatment with BzPO and reached a maximal increase relative to DMF-treated controls within 30 min. This near 3-fold increase in levels of 8-OHdG persisted for several hours, however, a reduction in 8-OHdG was observed 6 h after BzPO treatment, with levels in treated groups being 1.9-fold higher than in controls. There was no statistical difference between treated and control levels of 8-OHdG at the 12 or 24 h time points, indicating the rapid removal/repair of this base modification in these cells. Treatment of keratinocytes with either 1, 10 or 50 U. M BzPO demonstrated a dose-related increase in 8-OHdG levels ( Figure 2B ) and indicated that significant increases in the levels of this modified DNA base can occur at non-cytotoxic doses of BzPO. In contrast, treatment of cells with 50 |iM benzoic acid, a stable metabolite of BzPO, did not induce any modification to guanine. 
Modulation of 8-OHdG formation by metal chelators and glutathione
The protective effect of the copper chelator BCS against BzPOmediated DNA damage is shown in Figure 3 . Pretreatment of keratinocytes with 100 |iM BCS completely blocked formation of 8-OHdG by BzPO. In contrast to BCS, desferal, a Fe(m) chelator, did not offer protection against BzPO-mediated guanine modification. Neither BCS nor desferal affected control levels of 8-OHdG. These results are consistent with the view that copper, but not iron, is involved in the activation of BzPO to DNA damaging reactive intermediates (10-12). As shown in Figure 4A , a significant potentiation of the levels of 8-OHdG was achieved by depletion of cellular glutathione by BSO, a specific and potent inhibitor of glutathione synthesis (23) . Pretreatment of cells for 18 h with BSO, which lowered cellular levels of reduced glutathione by >90%, nearly doubled the amount of 8-OHdG formed in keratinocytes exposed to 10 (iM BzPO. In contrast, pretreatment of cells for 1 h with the monoethyl ester of glutathione offered protection against the DNA damaging actions of BzPO. This ethyl ester will more readily cross the cellular membrane than does glutathione, and its administration has been shown to increase intracellular glutathione levels (17) . Taken together these studies indicate a protective role for intracellular glutathione.
Discussion
We have previously demonstrated that BzPO/Cu(I) induces point mutations, as well as deletions, in the reporter tRNA gene supF (11). Sequence analysis indicated that a marked preponderance of the mutations occurred at specific sites in polyguanosine. Further, the majority of BzPO/Cu(I)-induced mutations were C:G->A:T transversions. Gas chromatography-mass spectrometry with selected-ion monitoring was used to determine the nature of potential promutagenic lesions (12) . Up to 20-fold increases in the levels of adenine-derived modified bases, up to 4-fold increases in guanine-and cytosinederived modified bases and only a <2-fold increase in thyminederived bases were observed after exposure of plasmid DNA to BzPO and copper. However, the guanine-modified base, 8-hydroxyguanine, was elevated to the highest net amount. Since G-»T transversion is the most common mispairing-type mutation produced by 8-hydroxyguanine in site specificity assays (24) (25) (26) , induction of this modified base may help explain the penchant of BzPO/Cu(I) to cause C:G->A:T transversions in the supF reporter plasmid. The present results indicate that treatment of cultured keratinocytes with BzPO also leads to formation of 8-OHdG and suggests that mechanisms elucidated in cell-free systems may be pertinent to intact cellular systems.
The metabolism of BzPO in keratinocytes proceeds via initial cleavage of the peroxide bond, yielding benzoyloxyl radicals which, in turn, can either fragment to form phenyl radicals and carbon dioxide or abstract H atoms from biomolecules to yield benzoic acid (9) . Benzoic acid is the major stable metabolite of BzPO produced by keratinocytes. The metabolism of BzPO appears to be copper dependent, in that treatment of cells with copper chelators retards formation of radical and non-radical metabolites. In contrast, iron chelators are without effect. While the reason for this metal ion specificity is unclear, BzPO-induced DNA strand breaks (10) and mutations (11) are also strictly Cu(I) dependent The present findings ( Figure 3 ) that pretreatment of keratinocytes with BCS, but not desferal, inhibits DNA base modification further highlights the specificity of copper in the activation of BzPO to DNA damaging intermediates. It is thought, in turn, that enhanced modification of purines by BzPO is principally determined by preferential sites of copper binding within DNA (11).
The involvement of a reactive intermediate(s) in the generation of promutagenic base modifications can be inferred from: (i) the copper dependence of BzPO-mediated 8-OHdG formation; (ii) the modulatory effects of glutathione elevation and depletion; and (iii) the lack of activity of benzoic acid. Electron paramagnetic resonance and scavenger studies had previously established that the benzoyloxyl radical mediated DNA strand breakage by BzPO (10). The nature of the chemical intermediate of BzPO that produces 8-OHdG is unclear at present. While this modified base can be abundantly produced by hydroxyl radicals, electron paramagnetic resonance coupled with spin trapping has failed to detect hydroxyl radical formation following activation of BzPO in cell-free and cellular systems. It seems likely that a copper-oxo complex participates in the observed base modification. It is known that transition metal-oxo complexes are mutagenic in bacterial (27) (28) (29) and mammalian (30,31) test systems.
The activation of BzPO occurs rapidly in keratinocytes, yielding a burst of radical intermediates. Concordantly, elevations in the levels of 8-OHdG are observed within minutes after treatment and are maximal within 1 h. However, levels of this modified guanine base are markedly reduced within 6 h and reach baseline levels within 12 h. This kinetic pattern indicates active repair of the damaged bases, as the observed reduction rate far exceeds the rate of diminution expected by simple dilution of lesions due to cell replication. This repair of 8-OHdG is presumably accomplished by a formamidopyrimidine DNA glycosylase (32) . It is reasonable to hypothesize that such DNA damage, if not repaired, could contribute to the activity of BzPO in enhancing the conversion of papillomas to carcinomas in bioassays. Nonetheless, it remains to be established what role radical-induced genetic damage plays in tumor promotion and progression in vivo.
